FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| INCOME : | ||
| Gross Sales | ₹635 Cr | ₹454 Cr |
| Sales | ₹633 Cr | ₹452 Cr |
| Job Work/ Contract Receipts | - | - |
| Processing Charges / Service Income | - | - |
| Revenue from property development | - | - |
| Other Operational Income | ₹2.14 Cr | ₹2.11 Cr |
| Less: Excise Duty | - | - |
| Net Sales | ₹635 Cr | ₹454 Cr |
| EXPENDITURE : | ||
| Increase/Decrease in Stock | ₹-32 Cr | ₹6.05 Cr |
| Raw Material Consumed | ₹486 Cr | ₹324 Cr |
| Opening Raw Materials | ₹109 Cr | - |
| Purchases Raw Materials | ₹488 Cr | ₹433 Cr |
| Closing Raw Materials | ₹111 Cr | ₹109 Cr |
| Other Direct Purchases / Brought in cost | - | - |
| Other raw material cost | - | - |
| Power & Fuel Cost | ₹6.19 Cr | ₹5.45 Cr |
| Electricity & Power | ₹6.18 Cr | ₹5.43 Cr |
| Oil, Fuel & Natural gas | - | - |
| Coals etc | - | - |
| Other power & fuel | ₹0.01 Cr | ₹0.01 Cr |
| Employee Cost | ₹33 Cr | ₹22 Cr |
| Salaries, Wages & Bonus | ₹22 Cr | ₹15 Cr |
| Contributions to EPF & Pension Funds | ₹1.08 Cr | ₹0.72 Cr |
| Workmen and Staff Welfare Expenses | ₹10 Cr | ₹6.49 Cr |
| Other Employees Cost | ₹0.32 Cr | ₹0.43 Cr |
| Other Manufacturing Expenses | ₹13 Cr | ₹15 Cr |
| Sub-contracted / Out sourced services | - | - |
| Processing Charges | ₹5.10 Cr | ₹8.35 Cr |
| Repairs and Maintenance | ₹3.06 Cr | ₹3.13 Cr |
| Packing Material Consumed | - | - |
| Other Mfg Exp | ₹4.61 Cr | ₹3.78 Cr |
| General and Administration Expenses | ₹30 Cr | ₹22 Cr |
| Rent , Rates & Taxes | ₹13 Cr | ₹13 Cr |
| Insurance | ₹0.95 Cr | ₹1.95 Cr |
| Printing and stationery | ₹0.79 Cr | ₹0.64 Cr |
| Professional and legal fees | ₹10 Cr | ₹3.71 Cr |
| Traveling and conveyance | ₹1.83 Cr | ₹1.14 Cr |
| Other Administration | ₹3.09 Cr | ₹1.54 Cr |
| Selling and Distribution Expenses | ₹6.90 Cr | ₹5.22 Cr |
| Advertisement & Sales Promotion | ₹4.15 Cr | ₹2.88 Cr |
| Sales Commissions & Incentives | - | - |
| Freight and Forwarding | ₹2.76 Cr | ₹2.34 Cr |
| Handling and Clearing Charges | - | - |
| Other Selling Expenses | - | - |
| Miscellaneous Expenses | ₹1.50 Cr | ₹1.62 Cr |
| Bad debts /advances written off | ₹0.57 Cr | - |
| Provision for doubtful debts | - | - |
| Losson disposal of fixed assets(net) | - | ₹0.11 Cr |
| Losson foreign exchange fluctuations | - | - |
| Losson sale of non-trade current investments | - | - |
| Other Miscellaneous Expenses | ₹0.93 Cr | ₹1.50 Cr |
| Less: Expenses Capitalised | - | - |
| Total Expenditure | ₹545 Cr | ₹401 Cr |
| Operating Profit (Excl OI) | ₹91 Cr | ₹52 Cr |
| Other Income | ₹3.66 Cr | ₹2.45 Cr |
| Interest Received | ₹0.42 Cr | ₹0.11 Cr |
| Dividend Received | ₹0.00 Cr | ₹0.00 Cr |
| Profit on sale of Fixed Assets | - | - |
| Profits on sale of Investments | - | - |
| Provision Written Back | - | - |
| Foreign Exchange Gains | ₹3.00 Cr | ₹0.98 Cr |
| Others | ₹0.24 Cr | ₹1.36 Cr |
| Operating Profit | ₹95 Cr | ₹55 Cr |
| Interest | ₹39 Cr | ₹22 Cr |
| InterestonDebenture / Bonds | - | - |
| Interest on Term Loan | ₹2.79 Cr | ₹2.33 Cr |
| Intereston Fixed deposits | - | - |
| Bank Charges etc | ₹1.81 Cr | ₹1.95 Cr |
| Other Interest | ₹35 Cr | ₹18 Cr |
| PBDT | ₹55 Cr | ₹33 Cr |
| Depreciation | ₹8.25 Cr | ₹5.04 Cr |
| Profit Before Taxation & Exceptional Items | ₹47 Cr | ₹27 Cr |
| Exceptional Income / Expenses | - | - |
| Profit Before Tax | ₹47 Cr | ₹27 Cr |
| Provision for Tax | ₹14 Cr | ₹7.75 Cr |
| Current Income Tax | ₹9.54 Cr | ₹7.12 Cr |
| Deferred Tax | ₹2.06 Cr | ₹0.64 Cr |
| Other taxes | ₹2.77 Cr | - |
| Profit After Tax | ₹33 Cr | ₹20 Cr |
| Extra items | - | - |
| Minority Interest | - | ₹0.00 Cr |
| Share of Associate | - | - |
| Other Consolidated Items | - | - |
| Consolidated Net Profit | ₹33 Cr | ₹20 Cr |
| Adjustments to PAT | - | ₹-0.34 Cr |
| Profit Balance B/F | ₹63 Cr | ₹44 Cr |
| Appropriations | ₹95 Cr | ₹63 Cr |
| General Reserves | - | - |
| Proposed Equity Dividend | - | - |
| Corporate dividend tax | - | - |
| Other Appropriation | ₹0.17 Cr | ₹0.33 Cr |
| Equity Dividend % | ₹7.00 | ₹7.00 |
| Earnings Per Share | ₹59.61 | ₹41.80 |
| Adjusted EPS | ₹59.61 | ₹41.80 |
Compare Income Statement of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,271.2 Cr | -0.6% | -2.7% | 219.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -0.6% |
-2.7% |
219.3% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses